UROLOGICAL CANCER | AUDITORIUM 2
See detail

12 May 2017

Program

Sessions

UROLOGICAL CANCER

 

08:00 AM Opening & registration
08:15 AM Welcome and introduction
Kris Maes [PT] | Francisco Mascarenhas [PT] 

08:30   PROSTATE CANCER

Round Table 1 | Image-guided diagnosis and treatment in prostate cancer
Chairmen: Adalgisa Guerra [PT] | Ferran Guedea [SP]

For how much longer will we be using the Gleason score? New kids on the block 
Fernando Algaba Arrea [SP]

Impact of MRI MP and MRI-targeted biopsies in diagnosis of prostate cancer 
Geert Villeirs [BE]

Role of MRI in staging and management of advanced prostate cancer
Nina Tunariu [UK]

Discussion

09:30 AM Round Table 2 | Controversies in treatment of low and medium risk prostate cancer: focal therapy
Chairmen: Patrick Kupelian [US] | Rafael Coelho [BR]

HIFU focal therapy 
Eric Potiron [FR]

Radiation focal therapy
Ferran Guedea [SP]

10:15 AM Coffee Break
10:45 AM Round Table 3 | How does the future treatment of low risk and intermediate risk PC looks like
Chairmen: Ferran Guedea [SP] | Arnulf Stenzl [BE]

For the radiation oncologist 
Patrick Kupelian ([US]

For the surgeon 
Steven Joniau [BE]

11:30 AM Debate | High risk prostate cancer: the future
Chairmen: Kris Maes [PT] | Steven Joniau [BE] | Filomena Pina [PT] | Luís Campos Pinheiro [PT]

Radiation therapy
Patrick Kupelian [US]

Radical prostatectomy
Arnulf Stenzl [DE]

Discussion

12:15 PM TESTICULAR CANCER
Chairmen: José Luís Passos Coelho [PT]

Surgical issues in testicular cancer: 
a) Adjuvant RPLND for whom?
b) Role of surgery for residual disease after chemotherapy 
Rafael Coelho [BR]

01:00  PM Lunch
02:00  PM PROSTATE CANCER

Round Table 4 | The management of recurrent prostate cancer after local treatment 
Chairmen: Arnulf Stenzl [DE] | Patrick Kupelian [US]

Salvage prostatectomy/lymphadenectomy: when and how 
Steven Joniau [BE]

Salvage radiotherapy: when and how
Ferran Guedea [SP]

Systemic therapy: when and how
Robert Jones [UK]

03:00 PM Round Table 5 | Future perspectives for treatment of advanced disease 
Chairmen: Fabio Schutz [BR] | Rosário Vieira [PT]

Management of mCRPC: chemotherapy for hormone naïve metastatic patients
Robert Jones [UK]

The power of precision medicine: PSMA radioligand therapy (PRLT) of end-stage prostate cancer patients selected by PSMA PET/CT
Aviral Sing [DE] | Richard Baum [DE] 

04:00 PM Coffee Break
04:30 PM BLADDER CANCER
Chairmen: Tomé Matos Lopes [PT] | Francisco Mascarenhas [PT]

Current and future treatment of NMIBC
Oscar Rodriguez [SP]

Who profits from neo-adjuvant chemotherapy for MIBC
Fabio Schutz [BR]

Multimodal treatment of MIBC: external beam radiotherapy and robotic limited surgery plus brachytherapy for bladder cancer
Elzbieta van der Steen-Banasik [NL]

Discussion 

06:00 PM Closing remarks
TBD

Download Schedule